These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 24360054)
1. [Histone deacetylase inhibits the growth and migration of human osteosarcoma cells]. Zhang ZL; Zhang AH; Feng ZQ; An L; Zhao QH Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(33):2680-5. PubMed ID: 24360054 [TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitors suppress the growth of human osteosarcomas in vitro and in vivo. Wu Z; Ma C; Shan Z; Ju Y; Li S; Zhao Q J BUON; 2013; 18(4):1032-7. PubMed ID: 24344034 [TBL] [Abstract][Full Text] [Related]
3. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor: effects on gene expression and growth of glioma cells in vitro and in vivo. Yin D; Ong JM; Hu J; Desmond JC; Kawamata N; Konda BM; Black KL; Koeffler HP Clin Cancer Res; 2007 Feb; 13(3):1045-52. PubMed ID: 17289901 [TBL] [Abstract][Full Text] [Related]
4. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancer. Shi YK; Li ZH; Han XQ; Yi JH; Wang ZH; Hou JL; Feng CR; Fang QH; Wang HH; Zhang PF; Wang FS; Shen J; Wang P Cancer Chemother Pharmacol; 2010 Nov; 66(6):1131-40. PubMed ID: 20838997 [TBL] [Abstract][Full Text] [Related]
5. Anticancer activity of SAHA, a potent histone deacetylase inhibitor, in NCI-H460 human large-cell lung carcinoma cells in vitro and in vivo. Zhao Y; Yu D; Wu H; Liu H; Zhou H; Gu R; Zhang R; Zhang S; Wu G Int J Oncol; 2014 Feb; 44(2):451-8. PubMed ID: 24297449 [TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitors repress chondrosarcoma cell proliferation. Zhu J; Gu J; Ma J; Xu Z; Tao H J BUON; 2015; 20(1):269-74. PubMed ID: 25778327 [TBL] [Abstract][Full Text] [Related]
7. Potential anti-cancer activity of N-hydroxy-7-(2-naphthylthio) heptanomide (HNHA), a histone deacetylase inhibitor, against breast cancer both in vitro and in vivo. Park KC; Kim SW; Park JH; Song EH; Yang JW; Chung HJ; Jung HJ; Suh JS; Kwon HJ; Choi SH Cancer Sci; 2011 Feb; 102(2):343-50. PubMed ID: 21159061 [TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitors profoundly decrease proliferation of human lymphoid cancer cell lines. Sakajiri S; Kumagai T; Kawamata N; Saitoh T; Said JW; Koeffler HP Exp Hematol; 2005 Jan; 33(1):53-61. PubMed ID: 15661398 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the effects of histone deacetylase inhibitors on cells from canine cancer cell lines. Kisseberth WC; Murahari S; London CA; Kulp SK; Chen CS Am J Vet Res; 2008 Jul; 69(7):938-45. PubMed ID: 18593248 [TBL] [Abstract][Full Text] [Related]
10. Growth of human prostate cancer cells is significantly suppressed in vitro with sodium butyrate through apoptosis. Qiu J; Gao Z; Shima H Oncol Rep; 2012 Jan; 27(1):160-7. PubMed ID: 21947091 [TBL] [Abstract][Full Text] [Related]
11. Enhancement of radiation response in osteosarcoma and rhabdomyosarcoma cell lines by histone deacetylase inhibition. Blattmann C; Oertel S; Ehemann V; Thiemann M; Huber PE; Bischof M; Witt O; Deubzer HE; Kulozik AE; Debus J; Weber KJ Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):237-45. PubMed ID: 20646843 [TBL] [Abstract][Full Text] [Related]
12. Histone post-translational modifications by HPLC-ESI-MS after HT29 cell treatment with histone deacetylase inhibitors. Naldi M; Calonghi N; Masotti L; Parolin C; Valente S; Mai A; Andrisano V Proteomics; 2009 Dec; 9(24):5437-45. PubMed ID: 19834889 [TBL] [Abstract][Full Text] [Related]
13. Human ovarian carcinoma cells: histone deacetylase inhibitors exhibit antiproliferative activity and potently induce apoptosis. Takai N; Kawamata N; Gui D; Said JW; Miyakawa I; Koeffler HP Cancer; 2004 Dec; 101(12):2760-70. PubMed ID: 15536623 [TBL] [Abstract][Full Text] [Related]
14. Enhanced suppression of tumor growth by concomitant treatment of human lung cancer cells with suberoylanilide hydroxamic acid and arsenic trioxide. Chien CW; Yao JH; Chang SY; Lee PC; Lee TC Toxicol Appl Pharmacol; 2011 Nov; 257(1):59-66. PubMed ID: 21889949 [TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitors SAHA and sodium butyrate block G1-to-S cell cycle progression in neurosphere formation by adult subventricular cells. Zhou Q; Dalgard CL; Wynder C; Doughty ML BMC Neurosci; 2011 May; 12():50. PubMed ID: 21615950 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the in vitro and in vivo antitumor activity of histone deacetylase inhibitors for the therapy of retinoblastoma. Dalgard CL; Van Quill KR; O'Brien JM Clin Cancer Res; 2008 May; 14(10):3113-23. PubMed ID: 18483379 [TBL] [Abstract][Full Text] [Related]
17. Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo. Butler LM; Agus DB; Scher HI; Higgins B; Rose A; Cordon-Cardo C; Thaler HT; Rifkind RA; Marks PA; Richon VM Cancer Res; 2000 Sep; 60(18):5165-70. PubMed ID: 11016644 [TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of SAHA, a novel histone deacetylase inhibitor, against murine B cell lymphoma A20 cells in vitro and in vivo. Yang B; Yu D; Liu J; Yang K; Wu G; Liu H Tumour Biol; 2015 Jul; 36(7):5051-61. PubMed ID: 25649979 [TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of suberoylanilide hydroxamic acid against human oral squamous cell carcinoma cell lines in vitro and in vivo. Nagumo T; Takaoka S; Yoshiba S; Ohashi M; Shirota T; Hatori M; Isobe T; Tachikawa T; Shintani S Oral Oncol; 2009 Sep; 45(9):766-70. PubMed ID: 19157955 [TBL] [Abstract][Full Text] [Related]
20. [Selective inducement effect of bacterial redox protein azurin on apoptosis of human osteosarcoma cell line U2OS]. Ye ZM; Miao XD; Yang DS; Xu RZ; Huang X; Ge FF Ai Zheng; 2005 Mar; 24(3):298-304. PubMed ID: 15757530 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]